Alzheimer’s charity chief: FDA approval for new drug is a historic moment
Aducanumab is the first new Alzheimer’s drug in almost 20 years.
Menu
Aducanumab is the first new Alzheimer’s drug in almost 20 years.
Starting this week, two new drugs – tocilizumab and sarilumab –will become a standard part of NHS treatment for Covid-19 patients admitted to intensive care.
First, we tried the antimalarial drug hydroxychloroquine. Then we tested the antiviral drug remdesivir. But new UK research gives the strongest indication yet we may have found
You pay with prison or your skin for the power to decide people’s lives or deaths, promote a product, monopolize a slice of the economy,
Subscribe to Reaction and receive unlimited access to the site, our daily email with analysis every evening and invites to online events.
© Copyright 2023 Reaction Digital Media Limited – All Rights Reserved. Registered Company in England & Wales – Company Number: 10166531.
